Ddx20, DEAD box helicase 20, is essential for the differentiation of oligodendrocyte and maintenance of myelin gene expression.
DEAD-box RNA helicase
Ddx20/Gemin3/DP103
myelin
oligodendrocytes
terminal differentiation
Journal
Glia
ISSN: 1098-1136
Titre abrégé: Glia
Pays: United States
ID NLM: 8806785
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
revised:
24
06
2021
received:
17
03
2021
accepted:
25
06
2021
pubmed:
8
7
2021
medline:
12
3
2022
entrez:
7
7
2021
Statut:
ppublish
Résumé
Oligodendrocytes form myelin sheaths that surround axons, contributing to saltatory conduction and proper central nervous system (CNS) function. Oligodendrocyte progenitor cells (OPCs) are generated during the embryonic stage and differentiate into myelinating oligodendrocytes postnatally. Ddx20 is a multifunctional, DEAD-box helicase involved in multiple cellular processes, including transcription, splicing, microRNA biogenesis, and translation. Although defects in each of these processes result in abnormal oligodendrocyte differentiation and myelination, the involvement of Ddx20 in oligodendrocyte terminal differentiation remains unknown. To address this question, we used Mbp-Cre mice to generate Ddx20 conditional knockout (cKO) mice to allow for the deletion of Ddx20 from mature oligodendrocytes. Mbp-Cre;Ddx20 cKO mice demonstrated small body sizes, behavioral abnormalities, muscle weakness, and short lifespans, with mortality by the age of 2 months old. Histological analyses demonstrated significant reductions in the number of mature oligodendrocytes and drastic reductions in the expression levels of myelin-associated mRNAs, such as Mbp and Plp at postnatal day 42. The number of OPCs did not change. A thin myelin layer was observed for large-diameter axons in Ddx20 cKO mice, based on electron microscopic analysis. A bromodeoxyuridine (BrdU) labeling experiment demonstrated that terminal differentiation was perturbed from ages 2 weeks to 7 weeks in the CNS of Mbp-Cre;Ddx20 cKO mice. The activation of mitogen-activated protein (MAP) kinase, which promotes myelination, was downregulated in the Ddx20 cKO mice based on immunohistochemical detection. These results indicate that Ddx20 is an essential factor for terminal differentiation of oligodendrocytes and maintenance of myelin gene expression.
Substances chimiques
DEAD Box Protein 20
EC 3.6.1.-
Ddx20 protein, mouse
EC 3.6.1.-
DEAD-box RNA Helicases
EC 3.6.4.13
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2559-2574Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Asipu, A., Mellor, A. L., & Blair, G. E. (2001). The specificity of the myelin basic protein gene promoter studied in transgenic mice. Biochemical and Biophysical Research Communications, 288, 809-818. https://doi.org/10.1006/bbrc.2001.5837
Barres, B. A., & Raff, M. C. (1993). Proliferation of oligodendrocyte precursor cells depends on electrical activity in axons. Nature, 361, 258-260. https://doi.org/10.1038/361258a0
Berger, J., Moser, H. W., & Forss-Petter, S. (2001). Leukodystrophies: Recent developments in genetics, molecular biology, pathogenesis and treatment. Current Opinion in Neurology, 14, 305-312. https://doi.org/10.1097/00019052-200106000-00007
Bin, J. M., Harris, S. N., & Kennedy, T. E. (2016). The oligodendrocyte-specific antibody 'CC1' binds quaking 7. Journal of Neurochemistry, 139(2), 181-186. https://doi.org/10.1111/jnc.13745
Boda, E., Viganò, F., Rosa, P., Fumagalli, M., Labat-Gest, V., Tempia, F., Abbracchio, M. P., Dimou, L., & Buffo, A. (2011). The GPR17 receptor in NG2 expressing cells: Focus on in vivo cell maturation and participation in acute trauma and chronic damage. Glia, 59(12), 1958-1973. https://doi.org/10.1002/glia.21237
Bu, J., Banki, A., Wu, Q., & Nishiyama, A. (2004). Increased NG2(+) glial cell proliferation and oligodendrocyte generation in the hypomyelinating mutant shiverer. Glia, 48(1), 51-63. https://doi.org/10.1002/glia.20055
Cai, J., Qi, Y., Hu, X., Tan, M., Liu, Z., Zhang, J., Li, Q., Sander, M., & Qiu, M. (2005). Generation of oligodendrocyte precursor cells from mouse dorsal spinal cord independent of Nkx6 regulation and Shh signaling. Neuron, 45(1), 41-53. https://doi.org/10.1016/j.neuron.2004.12.028
Campbell, L., Hunter, K. M., Mohaghegh, P., Tinsley, J. M., Brasch, M. A., & Davies, K. E. (2000). Direct interaction of Smn with dp103, a putative RNA helicase: A role for Smn in transcription regulation? Human Molecular Genetics, 9(7), 1093-1100. https://doi.org/10.1093/hmg/9.7.1093
Charroux, B., Pellizzoni, L., Perkinson, R. A., Shevchenko, A., Mann, M., & Dreyfuss, G. (1999). Gemin3: A novel dead box protein that interacts with Smn, the spinal muscular atrophy gene product, and is a component of gems. Journal of Cell Biology, 147(6), 1181-1194. https://doi.org/10.1083/jcb.147.6.1181
Curmi, F., & Cauchi, R. J. (2018). The multiple lives of DEAD-box RNA helicases DP103/DDX20/Gemin3. Biochemical Society Transactions, 46(2), 329-341. https://doi.org/10.1042/BST20180016
Darbelli, L., Choquet, K., Richard, S., & Kleinman, C. L. (2017). Transcriptome profiling of mouse brains with qki-deficient oligodendrocytes reveals major alternative splicing defects including self-splicing. Scientific Reports, 7(1), 7554. https://doi.org/10.1038/s41598-017-06211-1
Dimou, L., Simon, C., Kirchhoff, F., Takebayashi, H., & Götz, M. (2008). Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex. The Journal of Neuroscience, 28(41), 10434-10442. https://doi.org/10.1523/JNEUROSCI.2831-08.2008
Donker, R. B., Mouillet, J. F., Nelson, D. M., & Sadovsky, Y. (2007). The expression of Argonaute2 and related microRNA biogenesis proteins in normal and hypoxic trophoblasts. Molecular Human Reproduction, 13(4), 273-279. https://doi.org/10.1093/molehr/gam006
Emery, B., Agalliu, D., Cahoy, J. D., Watkins, T. A., Dugas, J. C., Mulinyawe, S. B., Ibrahim, A., Ligon, K. L., Rowitch, D. H., & Barres, B. A. (2009). Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell, 138(1), 172-185. https://doi.org/10.1016/j.cell.2009.04.031
Etxeberria, A., Hokanson, K. C., Dao, D. Q., Mayoral, S. R., Mei, F., Redmond, S. A., Ullian, E. M., & Chan, J. R. (2016). Dynamic modulation of myelination in response to visual stimuli alters optic nerve conduction velocity. The Journal of Neuroscience, 36(26), 6937-6948. https://doi.org/10.1523/JNEUROSCI.0908-16.2016
Fischer, C. A., & Morell, P. (1974). Turnover of proteins in myelin and myelin-like material of mouse brain. Brain Research, 74, 51-65. https://doi.org/10.1016/0006-8993(74)90111-5
Franklin, R. J., & Ffrench-Constant, C. (2008). Remyelination in the CNS: From biology to therapy. Nature Reviews Neuroscience, 9(11), 839-855. https://doi.org/10.1038/nrn2480
Frieler, R. A., Nadimpalli, S., Boland, L. K., Xie, A., Kooistra, L. J., Song, J., Chung, Y., Cho, K. W., Lumeng, C. N., Wang, M. M., & Mortensen, R. M. (2015). Depletion of macrophages in CD11b diphtheria toxin receptor mice induces brain inflammation and enhances inflammatory signaling during traumatic brain injury. Brain Research, 1624, 103-112. https://doi.org/10.1016/j.brainres.2015.07.011
Gibson, E. M., Purger, D., Mount, C. W., Goldstein, A. K., Lin, G. L., Wood, L. S., Inema, I., Miller, S. E., Bieri, G., Zuchero, J. B., Barres, B. A., Woo, P. J., Vogel, H., & Monje, M. (2014). Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science, 344(6183), 1252304. https://doi.org/10.1126/science.1252304
Gillian, A. L., & Svaren, J. (2004). The Ddx20/DP103 dead box protein represses transcriptional activation by Egr2/Krox-20. Journal of Biological Chemistry, 279(10), 9056-9063. https://doi.org/10.1074/jbc.M309308200
Gubitz, A. K., Feng, W., & Dreyfuss, G. (2004). The SMN complex. Experimental Cell Research, 296(1), 51-56. https://doi.org/10.1016/j.yexcr.2004.03.022
Hayakawa-Yano, Y., Suyama, S., Nogami, M., Yugami, M., Koya, I., Furukawa, T., Zhou, L., Abe, M., Sakimura, K., Takebayashi, H., Nakanishi, A., Okano, H., & Yano, M. (2017). An RNA-binding protein, Qki5, regulates embryonic neural stem cells through pre-mRNA processing in cell adhesion signaling. Genes & Development, 31, 1910-1925. https://doi.org/10.1101/gad.300822.117
Hoch-Kraft, P., White, R., Tenzer, S., Krämer-Albers, E. M., Trotter, J., & Gonsior, C. (2018). Dual role of the RNA helicase DDX5 in post-transcriptional regulation of myelin basic protein in oligodendrocytes. Journal of Cell Science, 131(9), jcs204750. https://doi.org/10.1242/jcs.204750
Horie, M., Watanabe, K., Bepari, A. K., Nashimoto, J., Araki, K., Sano, H., Chiken, S., Nambu, A., Ono, K., Ikenaka, K., Kakita, A., Yamamura, K. I., & Takebayashi, H. (2014). Disruption of Actin-binding domain-containing dystonin protein causes dystonia musculorum in mice. European Journal of Neuroscience, 40(10), 3458-3471. https://doi.org/10.1111/ejn.12711
Horie, M., Yoshioka, N., Kusumi, S., Sano, H., Kurose, M., Watanabe-Iida, I., Hossain, I., Chiken, S., Abe, M., Yamamura, K., Sakimura, K., Nambu, A., Shibata, M., & Takebayashi, H. (2020). Disruption of dystonin in Schwann cells results in late-onset neuropathy and sensory ataxia. Glia, 68(11), 2330-2344. https://doi.org/10.1002/glia.23843
Hou, L., Qu, X., Qiu, X., Huang, R., Zhao, X., & Wang, Q. (2020). Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson's disease model. Journal of Neuroinflammation, 17(1), 148. https://doi.org/10.1186/s12974-020-01823-3
Hutvágner, G., & Zamore, P. D. (2002). A microRNA in a multiple-turnover RNAi enzyme complex. Science, 297(5589), 2056-2060. https://doi.org/10.1126/science.1073827
Ikeda, M., Hossain, M. I., Zhou, L., Horie, M., Ikenaka, K., Horii, A., & Takebayashi, H. (2018). Histological detection of dynamic glial responses in the dysmyelinating Tabby-jimpy mutant brain. Anatomical Science International, 93(1), 119-127. https://doi.org/10.1007/s12565-016-0383-5
Ishii, A., Furusho, M., Dupree, J. L., & Bansal, R. (2014). Role of ERK1/2 MAPK signaling in the maintenance of myelin and axonal integrity in the adult CNS. The Journal of Neuroscience, 34(48), 16031-16045. https://doi.org/10.1523/JNEUROSCI.3360-14.2014
Ishii, A., Furusho, M., Macklin, W., & Bansal, R. (2019). Independent and cooperative roles of the Mek/ERK1/2-MAPK and PI3K/Akt/mTOR pathways during developmental myelination and in adulthood. Glia, 67(7), 1277-1295. https://doi.org/10.1002/glia.23602
Jessen, K. R., & Mirsky, R. (2008). Negative regulation of myelination: Relevance for development, injury, and demyelinating disease. Glia, 56(14), 1552-1565. https://doi.org/10.1002/glia.20761
Kagawa, T., Ikenaka, K., Inoue, Y., Kuriyama, S., Tsujii, T., Nakao, J., Nakajima, K., Aruga, J., Okano, H., & Mikoshiba, K. (1994). Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron, 13(2), 427-442. https://doi.org/10.1016/0896-6273(94)90358-1
Kellaris, G., Khan, K., Baig, S. M., Tsai, I. C., Zamora, F. M., Ruggieri, P., Natowicz, M. R., & Katsanis, N. (2018). A hypomorphic inherited pathogenic variant in DDX3X causes male intellectual disability with additional neurodevelopmental and neurodegenerative features. Human Genomics, 12(1), 11. https://doi.org/10.1186/s40246-018-0141-y
Kocur, M., Schneider, R., Pulm, A. K., Bauer, J., Kropp, S., Gliem, M., Ingwersen, J., Goebels, N., Alferink, J., Prozorovski, T., Aktas, O., & Scheu, S. (2015). IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity. Acta Neuropathologica Communications, 3, 20. https://doi.org/10.1186/s40478-015-0192-4
LeBlanc, S. E., Jang, S. W., Ward, R. M., Wrabetz, L., & Svaren, J. (2006). Direct regulation of myelin protein zero expression by the Egr2 transactivator. Journal of Biological Chemistry, 281(9), 5453-5460. https://doi.org/10.1074/jbc.M512159200
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P. W., Pellerin, L., Magistretti, P. J., & Rothstein, J. D. (2012). Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature, 487(7408), 443-448. https://doi.org/10.1038/nature11314
Lemke, G. (1988). Unwrapping the genes of myelin. Neuron, 1(7), 535-543. https://doi.org/10.1016/0896-6273(88)90103-1
Lennox, A. L., Hoye, M. L., Jiang, R., Johnson-Kerner, B. L., Suit, L. A., Venkataramanan, S., Sheehan, C. J., Alsina, F. C., Fregeau, B., Aldinger, K. A., Moey, C., Lobach, I., Afenjar, A., Babovic-Vuksanovic, D., Bézieau, S., Blackburn, P. R., Bunt, J., Burglen, L., Campeau, P. M., … Sherr, E. H. (2020). Pathogenic DDX3X mutations impair RNA metabolism and neurogenesis during fetal cortical development. Neuron, 106(3), 404-420. https://doi.org/10.1016/j.neuron.2020.01.042
Li, D., Tong, L., Kawano, H., Liu, N., Yan, H. J., Zhao, L., & Li, H. P. (2016). Regulation and role of ERK phosphorylation in glial cells following a nigrostriatal pathway injury. Brain Research, 1648, 90-100. https://doi.org/10.1016/j.brainres.2016.07.008
Li, Z., Zhang, Y., Li, D., & Feng, Y. (2000). Destabilization and mislocalization of myelin basic protein mRNAs in quaking dysmyelination lacking the QKI RNA-binding proteins. The Journal of Neuroscience, 20(13), 4944-4953. https://doi.org/10.1523/JNEUROSCI.20-13-04944.2000
Lu, Q. R., Sun, T., Zhu, Z., Ma, N., Garcia, M., Stiles, C. D., & Rowitch, D. H. (2002). Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell, 109(1), 75-86. https://doi.org/10.1016/s0092-8674(02)00678-5
Ma, J., Matsumoto, M., Tanaka, K. F., Takebayashi, H., & Ikenaka, K. (2006). An animal model for late onset chronic demyelination disease caused by failed terminal differentiation of oligodendrocytes. Neuron Glia Biology, 2(2), 81-91. https://doi.org/10.1017/S1740925X06000056
Mahad, D. H., Trapp, B. D., & Lassmann, H. (2015). Pathological mechanisms in progressive multiple sclerosis. Lancet Neurology, 14(2), 183-193. https://doi.org/10.1016/S1474-4422(14)70256-X
Mallon, B. S., & Macklin, W. B. (2002). Overexpression of the 3′-untranslated region of myelin proteolipid protein mRNA leads to reduced expression of endogenous proteolipid mRNA. Neurochemical Research, 27(11), 1349-1360. https://doi.org/10.1023/a:1021623700009
Morizawa, Y. M., Hirayama, Y., Ohno, N., Shibata, S., Shigetomi, E., Sui, Y., Nabekura, J., Sato, K., Okajima, F., Takebayashi, H., Okano, H., & Koizumi, S. (2017). Reactive astrocytes function as phagocytes after brain ischemia via ABCA1-mediated pathway. Nature Commununications, 8(1), 28. https://doi.org/10.1038/s41467-017-00037-1
Mourelatos, Z., Dostie, J., Paushkin, S., Sharma, A., Charroux, B., Abel, L., Rappsilber, J., Mann, M., & Dreyfuss, G. (2002). miRNPs: A novel class of ribonucleoproteins containing numerous microRNAs. Genes & Development, 16(6), 720-728. https://doi.org/10.1101/gad.974702
Mot, A. I., Depp, C., & Nave, K. A. (2018). An emerging role of dysfunctional axon-oligodendrocyte coupling in neurodegenerative diseases. Dialogues in Clinical Neuroscience, 20(4), 283-292.
Mouillet, J. F., Yax, X., Ou, Q., Jin, L., Muglia, L. J., Crawford, P. A., & Sadovsky, Y. (2008). DEAD-box protein-103 (DP103, Ddx20) is essential for early embryonic development and modulates ovarian morphology and function. Endocrinology, 149(5), 2168-2175. https://doi.org/10.1210/en.2007-1237
Nave, K. A., Sereda, M. W., & Ehrenreich, H. (2007). Mechanisms of disease: Inherited demyelinating neuropathies-From basic to clinical research. Nature Clinical Practice Neurology, 3(8), 453-464. https://doi.org/10.1038/ncpneuro0583
Niwa-Kawakita, M., Abramowski, V., Kalamarides, M., Thomas, G., & Giovannini, M. (2000). Targeted expression of Cre recombinase to myelinating cells of the central nervous system in transgenic mice. Genesis, 26(2), 127-129. https://doi.org/10.1002/(sici)1526-968x(200002)26:2<127::aid-gene8>3.0.co;2-h
Novak, A., Guo, C., Yang, W., Nagy, A., & Lobe, C. G. (2000). Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis, 28(3-4), 147-155. https://doi.org/10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G
O'Meara, R. W., Cummings, S. E., De Repentigny, Y., McFall, E., Michalski, J. P., Deguise, M. O., Gibeault, S., & Kothary, R. (2017). Oligodendrocyte development and CNS myelination are unaffected in a mouse model of severe spinal muscular atrophy. Human Molecular Genetics, 26(2), 282-292. https://doi.org/10.1093/hmg/ddw385
Ou, Q., Mouillet, J. F., Yan, X., Dorn, C., Crawford, P. A., & Sadovsky, Y. (2001). The DEAD box protein DP103 is a regulator of steroidogenic factor-1. Molecular Endocrinology, 15(1), 69-79. https://doi.org/10.1210/mend.15.1.0580
Peckham, H., Giuffrida, L., Wood, R., Gonsalvez, D., Ferner, A., Kilpatrick, T. J., Murray, S. S., & Xiao, J. (2016). Fyn is an intermediate kinase that BDNF utilizes to promote oligodendrocyte myelination. Glia, 64(2), 255-269. https://doi.org/10.1002/glia.22927
Peles, E., & Salzer, J. L. (2000). Molecular domains of myelinated axons. Current Opinion in Neurobiology, 10(5), 558-565. https://doi.org/10.1016/s0959-4388(00)00122-7
Rivers, L. E., Young, K. M., Rizzi, M., Jamen, F., Psachoulia, K., Wade, A., Kessaris, N., & Richardson, W. D. (2008). PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nature Neuroscience, 11(12), 1392-1401. https://doi.org/10.1038/nn.2220
Sabri, M. I., Bone, A. H., & Davison, A. N. (1974). Turnover of myelin and other structural proteins in the developing rat brain. Biochemical Journal, 142, 499-507. https://doi.org/10.1042/bj1420499
Salpietro, V., Efthymiou, S., Manole, A., Maurya, B., Wiethoff, S., Ashokkumar, B., Cutrupi, M. C., Dipasquale, V., Manti, S., Botia, J. A., Ryten, M., Vandrovcova, J., Bello, O. D., Bettencourt, C., Mankad, K., Mukherjee, A., Mutsuddi, M., & Houlden, H. (2018). A loss-of-function homozygous mutation in DDX59 implicates a conserved DEAD-box RNA helicase in nervous system development and function. Human Mutation, 39(2), 187-192. https://doi.org/10.1002/humu.23368
Schrank, B., Götz, R., Gunnersen, J. M., Ure, J. M., Toyka, K. V., Smith, A. G., & Sendtner, M. (1997). Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proceedings of the National Academy of Sciences of the United States of America, 94(18), 9920-9925. https://doi.org/10.1073/pnas.94.18.9920
Sherman, D. L., & Brophy, P. J. (2005). Mechanisms of axon ensheathment and myelin growth. Nature Reviews Neuroscience, 6, 683-690. https://doi.org/10.1038/nrn1743
Spassky, N., Goujet-Zalc, C., Parmantier, E., Olivier, C., Martinez, S., Ivanova, A., Ikenaka, K., Macklin, W., Cerruti, I., Zalc, B., & Thomas, J. L. (1998). Multiple restricted origin of oligodendrocytes. The Journal of Neuroscience, 18(20), 8331-8343. https://doi.org/10.1523/JNEUROSCI.18-20-08331.1998
Stolt, C. C., Rehberg, S., Ader, M., Lommes, P., Riethmacher, D., Schachner, M., Bartsch, U., & Wegner, M. (2002). Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes & Development, 16(2), 165-170. https://doi.org/10.1101/gad.215802
Suo, N., Guo, Y. E., He, B., Gu, H., & Xie, X. (2019). Inhibition of MAPK/ERK pathway promotes oligodendrocytes generation and recovery of demyelinating diseases. Glia, 67(7), 1320-1332. https://doi.org/10.1002/glia.23606
Takebayashi, H., & Ikenaka, K. (2015). Oligodendrocyte generation during mouse development. Glia, 63(8), 1350-1356. https://doi.org/10.1002/glia.22863
Takebayashi, H., Nabeshima, Y., Yoshida, S., Chisaka, O., Ikenaka, K., & Nabeshima, Y. (2002). The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Current Biology, 12(13), 1157-1163. https://doi.org/10.1016/s0960-9822(02)00926-0
Takebayashi, H., Yoshida, S., Sugimori, M., Kosako, H., Kominami, R., Nakafuku, M., & Nabeshima, Y. (2000). Dynamic expression of basic helix-loop-helix Olig family members: Implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3. Mechanisms of Development, 99, 143-148. https://doi.org/10.1016/s0925-4773(00)00466-4
Tsujita, M., Mori, H., Watanabe, M., Suzuki, M., Miyazaki, J., & Mishina, M. (1999). Cerebellar granule cell-specific and inducible expression of Cre recombinase in the mouse. The Journal of Neuroscience, 19(23), 10318-10323. https://doi.org/10.1523/JNEUROSCI.19-23-10318.1999
Vallstedt, A., Klos, J. M., & Ericson, J. (2005). Multiple dorsoventral origins of oligodendrocyte generation in the spinal cord and hindbrain. Neuron, 45(1), 55-67. https://doi.org/10.1016/j.neuron.2004.12.026
Wake, H., Lee, P. R., & Fields, R. D. (2011). Control of local protein synthesis and initial events in myelination by action potentials. Science, 333(6049), 1647-1651. https://doi.org/10.1126/science.1206998
Wang, E., & Cambi, F. (2012). MicroRNA expression in mouse oligodendrocytes and regulation of proteolipid protein gene expression. Journal of Neuroscience Research, 90(9), 1701-1712. https://doi.org/10.1002/jnr.23055
Wang, E., Dimova, N., Sperle, K., Huang, Z., Lock, L., McCulloch, M. C., Edgar, J. M., Hobson, G. M., & Cambi, F. (2008). Deletion of a splicing enhancer disrupts PLP1/DM20 ratio and myelin stability. Experimental Neurology, 214(2), 322-330. https://doi.org/10.1016/j.expneurol.2008.09.001
Webster, B., Hansen, L., Adame, A., Crews, L., Torrance, M., Thal, L., & Masliah, E. (2006). Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease. Journal of Neuropathology & Experimental Neurology, 65(2), 142-151. https://doi.org/10.1097/01.jnen.0000199599.63204.6f
Wu, J. I., Reed, R. B., Grabowski, P. J., & Artzt, K. (2002). Function of quaking in myelination: Regulation of alternative splicing. Proceedings of the National Academy of Sciences of the United States of America, 99(7), 4233-4238. https://doi.org/10.1073/pnas.072090399
Xiao, L., Ohayon, D., McKenzie, I. A., Sinclair-Wilson, A., Wright, J. L., Fudge, A. D., Emery, B., Li, H., & Richardson, W. D. (2016). Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning. Nature Neuroscience, 19(9), 1210-1217. https://doi.org/10.1038/nn.4351
Yamamura, T., Konola, J. T., Wekerle, H., & Lees, M. B. (1991). Monoclonal antibodies against myelin proteolipid protein: Identification and characterization of two major determinants. Journal of Neurochemistry, 57(5), 1671-1680. https://doi.org/10.1111/j.1471-4159.1991.tb06367.x
Yang, M., Xu, W., Wang, Y., Jiang, X., Li, Y., Yang, Y., & Yuan, H. (2018). CD11b-activated Src signal attenuates neuroinflammatory pain by orchestrating inflammatory and anti-inflammatory cytokines in microglia. Molecular Pain, 14, 1744806918808150. https://doi.org/10.1177/1744806918808150
Zhan, R., Yamamoto, M., Ueki, T., Yoshioka, N., Tanaka, K., Morisaki, H., Seiwa, C., Yamamoto, Y., Kawano, H., Tsuruo, Y., Watanabe, K., Asou, H., & Aiso, S. (2013). A DEAD-box RNA helicase Ddx54 protein in oligodendrocytes is indispensable for myelination in the central nervous system. Journal of Neuroscience Research, 91(3), 335-348. https://doi.org/10.1002/jnr.23162
Zhao, X., He, X., Han, X., Yu, Y., Ye, F., Chen, Y., Hoang, T. N., Xu, X., Mi, Q. S., Xin, M., Wang, F., Appel, B., & Lu, Q. R. (2010). MicroRNA-mediated control of oligodendrocyte differentiation. Neuron, 65(5), 612-626. https://doi.org/10.1016/j.neuron.2010.02.018
Zhou, L., Hossain, M. I., Yamazaki, M., Abe, M., Natsume, R., Konno, K., Kageyama, S., Komatsu, M., Watanabe, M., Sakimura, K., & Takebayashi, H. (2018). Deletion of exons encoding carboxypeptidase domain of Nna1 results in Purkinje cell degeneration (pcd) phenotype. Journal of Neurochemistry, 147(4), 557-572. https://doi.org/10.1111/jnc.14591
Zhou, Q., & Anderson, D. J. (2002). The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell, 109(1), 61-73. https://doi.org/10.1016/s0092-8674(02)00677-3